# Switching Antipsychotics: Abrupt Discontinuation Versus Overlap

> **NCT02640300** · PHASE4 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 33 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Clozapine

## Key facts

- **NCT ID:** NCT02640300
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02640300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02640300, "Switching Antipsychotics: Abrupt Discontinuation Versus Overlap". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02640300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*